How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
67
FULC Quote, Financials, Valuation and Earnings
Last price:
$10.49
Seasonality move
:
-23.08%
Day range:
$10.48 - $11.11
52-week range:
$2.32 - $15.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.92x
Volume:
496.9K
Avg. volume:
802K
1-year change:
170.71%
Market cap:
$580.1M
Revenue:
$80M
EPS (TTM):
-$1.18
Earnings Data
Next earnings date for FULC
Feb 24
2026
Most recent earnings per share
-$0.31
Missed by $0.02
(Oct 29/2025)
Consensus Estimate
-$0.29
(Oct 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FULC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$0.29 | -- |
| 02/24/2026 | Q4 | -- | -- | -- | -$0.30 | -- |
| 10/29/2025 | Q3 | -- | -- | -$0.31 | -$0.29 | -$0.02 |
| 07/29/2025 | Q2 | -- | -- | -$0.28 | -$0.29 | $0.01 |
| 05/13/2025 | Q1 | -- | -- | -$0.28 | -$0.33 | $0.04 |
| 02/25/2025 | Q4 | -- | -- | -$0.31 | -$0.29 | -$0.02 |
| 11/13/2024 | Q3 | -- | -- | -$0.35 | -$0.40 | $0.05 |
| 07/31/2024 | Q2 | $41.1M | $80M | $0.87 | $0.06 | $0.81 |
| 05/13/2024 | Q1 | $360.1K | -- | -$0.43 | -$0.44 | $0.00 |
| 02/27/2024 | Q4 | $394.8K | $871K | -$0.40 | -$0.43 | $0.03 |
| 11/07/2023 | Q3 | $1.1M | $759K | -$0.39 | -$0.44 | $0.05 |
| 08/03/2023 | Q2 | -- | $880K | -$0.38 | -- | -- |
| 05/15/2023 | Q1 | -- | $295K | -$0.41 | -- | -- |
| 03/09/2023 | Q4 | -- | $685K | -$0.50 | -- | -- |
| 11/08/2022 | Q3 | -- | $1.2M | -$0.51 | -- | -- |
| 08/11/2022 | Q2 | -- | $1.9M | -$0.83 | -- | -- |
| 05/09/2022 | Q1 | -- | $2.6M | -$0.64 | -- | -- |
| 03/03/2022 | Q4 | -- | $5.1M | -$0.58 | -- | -- |
| 11/04/2021 | Q3 | -- | $4.9M | -$0.57 | -- | -- |
| 08/10/2021 | Q2 | -- | $4.4M | -$0.60 | -- | -- |
| 05/06/2021 | Q1 | -- | $4.8M | -$0.54 | -- | -- |
| 03/04/2021 | Q4 | -- | $4.2M | -$0.64 | -- | -- |
| 11/10/2020 | Q3 | -- | $1.8M | -$0.70 | -- | -- |
| 08/11/2020 | Q2 | -- | $2M | -$0.66 | -- | -- |
| 05/13/2020 | Q1 | -- | $750K | -$0.81 | -- | -- |
| 03/05/2020 | Q4 | -- | -- | -$0.71 | -- | -- |
| 11/14/2019 | Q3 | -- | -- | -$0.97 | -- | -- |
| 08/26/2019 | Q2 | -- | -- | -$0.71 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$1.71 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.69 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.64 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.53 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.33 | -- | -- |
Fulcrum Therapeutics, Inc. Earnings Questions
-
How Much did Fulcrum Therapeutics, Inc. Generate in Revenue Last Quarter?
Fulcrum Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Fulcrum Therapeutics, Inc. Beat Earnings Last Quarter?
Fulcrum Therapeutics, Inc. announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.29 per share.
-
Is Fulcrum Therapeutics, Inc. Profitable?
Fulcrum Therapeutics, Inc. reported -$300K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Fulcrum Therapeutics, Inc. EPS Next Year?
Fulcrum Therapeutics, Inc.'s earnings are forecast to decrease from -$0.16 per share to -$1.17 per share next year representing a decrease of -676.76%.
-
When is Fulcrum Therapeutics, Inc.'s Earnings Date?
Fulcrum Therapeutics, Inc.'s next earnings date is February 24, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 43x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 43x
Alerts
Sell
49
HYMC alert for Feb 3
Hycroft Mining Holding Corp. [HYMC] is up 19.68% over the past day.
Buy
67
FBRX alert for Feb 3
Forte Biosciences, Inc. [FBRX] is down 0.2% over the past day.
Buy
72
BNR alert for Feb 3
Burning Rock Biotech Ltd. [BNR] is down 15.43% over the past day.
